US-sanctioned Chinese companies are increasingly turning to open-source research to innovate and reverse-engineer restricted foreign technology, with a 72 per cent surge in scientific literature citations in their patent applications, according to a new study.
While the United States said it expanded its Entity List to safeguard national security and preserve its technological edge, an analysis of Chinese patent filings over the 12 years until 2022 showed that US restrictions on access to technology had driven Chinese firms to widely source publicly available scientific knowledge and conduct more of their own research. #Science is awesome 🧬🦾🚀🤯 #A Glance of China 行摄中国
https://www.scmp.com/news..
